Close Menu

NEW YORK — The US Food and Drug Administration on Monday granted Emergency Use Authorization for a PCR-based SARS-CoV-2 test developed by laboratory services provider LifeHope Labs.

The LifeHope 2019-nCoV Real-Time RT-PCR Diagnostic Panel, which is based on the US Centers for Disease Control and Prevention's CDC 2019-Novel Coronavirus Real-Time RT-PCR Diagnostic Panel, is designed to detect two regions in the SARS-CoV-2 nucleocapsid gene in upper respiratory and bronchoalveolar lavage specimens.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
14

This webinar will describe a rapid metagenomics assay under development for human pathogens, including the SARS-CoV-2 coronavirus.

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

Jul
23

This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.